Holen Sie sich die Stockscreener-App
17.00
0.06%
0.01
Schlusskurs vom Vortag:
$16.99
Offen:
$17.11
24-Stunden-Volumen:
339.70K
Relative Volume:
0.62
Marktkapitalisierung:
$1.03B
Einnahmen:
$688.00K
Nettoeinkommen (Verlust:
$-170.19M
KGV:
-5.7432
EPS:
-2.96
Netto-Cashflow:
$-154.68M
1W Leistung:
+3.09%
1M Leistung:
+0.77%
6M Leistung:
-12.69%
1J Leistung:
-39.37%
1-Tages-Spanne:
$16.86
$17.58
1-Wochen-Bereich:
$16.12
$17.58
52-Wochen-Spanne:
$10.91
$40.26
Spyre Therapeutics Inc Stock (SYRE) Company Profile
Firmenname
Spyre Therapeutics Inc
Sektor
Branche
Telefon
(617) 651-5940
Adresse
221 CRESCENT STREET, WALTHAM
Vergleichen Sie SYRE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SYRE
Spyre Therapeutics Inc
|
17.00 | 1.03B | 688.00K | -170.19M | -154.68M | -2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Spyre Therapeutics Inc Stock (SYRE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-08 | Eingeleitet | Leerink Partners | Outperform |
| 2025-03-18 | Eingeleitet | Wolfe Research | Outperform |
| 2024-09-04 | Eingeleitet | Wedbush | Outperform |
| 2024-07-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-05-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-20 | Eingeleitet | BTIG Research | Buy |
| 2023-12-11 | Eingeleitet | Guggenheim | Buy |
| 2023-12-11 | Eingeleitet | Jefferies | Buy |
| 2020-05-04 | Eingeleitet | Piper Sandler | Overweight |
| 2019-03-21 | Eingeleitet | JP Morgan | Overweight |
| 2018-09-04 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2018-04-24 | Eingeleitet | Evercore ISI | Outperform |
| 2018-03-14 | Bestätigt | Needham | Buy |
Alle ansehen
Spyre Therapeutics Inc Aktie (SYRE) Neueste Nachrichten
Can Spyre Therapeutics Inc. hit a new high this monthQuarterly Portfolio Review & Risk Managed Investment Strategies - Newser
Spyre Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Chart Watch & Risk Controlled Daily Trade Plans - Newser
How to build a custom watchlist for Spyre Therapeutics Inc.Market Movement Recap & Technical Entry and Exit Tips - Newser
Chart Analysts Warn of Resistance Near Spyre Therapeutics Inc. Price2025 Trading Volume Trends & Verified Swing Trading Watchlist - beatles.ru
Tools to assess Spyre Therapeutics Inc.’s risk profileJuly 2025 Selloffs & Free Fast Gain Swing Trade Alerts - Newser
Does Spyre Therapeutics Inc. stock benefit from AI growthWeekly Risk Report & Verified Momentum Watchlists - خودرو بانک
Combining price and volume data for Spyre Therapeutics Inc.2025 EndofYear Setup & Trade Opportunity Analysis Reports - Newser
Spyre Therapeutics Announces Grants of Inducement Awards - The Manila Times
How sensitive is Spyre Therapeutics Inc. to inflationMarket Activity Recap & Low Drawdown Trading Techniques - خودرو بانک
Does Spyre Therapeutics Inc. have high return on assetsJuly 2025 Update & Accurate Intraday Trade Tips - خودرو بانک
Will Spyre Therapeutics Inc. rebound enough to break evenTrade Risk Report & Verified Technical Signals - Newser
Is it time to cut losses on Spyre Therapeutics Inc.July 2025 Reactions & Long-Term Growth Plans - Newser
What’s the RSI of Spyre Therapeutics Inc. stockMarket Weekly Review & Capital Protection Trading Alerts - khodrobank.com
Dow Update: Does Spyre Therapeutics Inc. align with a passive investing strategyMarket Activity Report & Fast Gain Swing Trade Alerts - خودرو بانک
Insider Trends: Can Spyre Therapeutics Inc. expand its profit marginsJuly 2025 Chart Watch & Fast Momentum Entry Tips - خودرو بانک
Chart based exit strategy for Spyre Therapeutics Inc.Trade Ideas & Risk Controlled Swing Trade Alerts - Newser
Published on: 2025-09-04 02:33:02 - Newser
Visualizing Spyre Therapeutics Inc. stock with heatmaps2025 Key Lessons & Weekly Breakout Stock Alerts - Newser
Relative strength of Spyre Therapeutics Inc. in sector analysisWeekly Trade Analysis & Reliable Intraday Trade Alerts - Newser
What technical models suggest about Spyre Therapeutics Inc.’s comebackWeekly Gains Report & Weekly Setup with High ROI Potential - Newser
CFO’s Major Stock Sale Shakes Up Spyre Therapeutics! - TipRanks
What is Spyre Therapeutics Inc.’s valuation compared to sectorWeekly Trade Analysis & Growth-Oriented Investment Plans - خودرو بانک
Can Spyre Therapeutics Inc. recover in the next quarter2025 Institutional Moves & Accurate Entry/Exit Alerts - Newser
Combining machine learning predictions for Spyre Therapeutics Inc.Market Rally & Long-Term Safe Investment Ideas - Newser
Spyre Therapeutics CFO Burrows Scott L sells 18,428 shares at $16.26 on 2025-09-02. - AInvest
Should you hold or exit Spyre Therapeutics Inc. now2025 AllTime Highs & Free Daily Entry Point Trade Alerts - Newser
Custom watchlist performance reports with Spyre Therapeutics Inc.Portfolio Update Summary & Stepwise Swing Trade Plans - Newser
What are the future prospects of Spyre Therapeutics Inc.IPO Watch & Proven Capital Preservation Methods - خودرو بانک
Spyre Therapeutics Inc. stock trend forecastEarnings Growth Report & Smart Investment Allocation Insights - Newser
Is Spyre Therapeutics Inc. stock a buy or sell2025 Dividend Review & Low Risk High Win Rate Picks - خودرو بانک
Does Spyre Therapeutics Inc. align with a passive investing strategyJuly 2025 PreEarnings & Low Risk High Win Rate Picks - خودرو بانک
Is Spyre Therapeutics Inc. trending in predictive chart models2025 Price Action Summary & Safe Swing Trade Setup Alerts - Newser
Is Spyre Therapeutics Inc. benefiting from interest rate changesJuly 2025 Sector Moves & Verified Chart Pattern Trade Signals - خودرو بانک
Can Spyre Therapeutics Inc. disrupt its industryPortfolio Return Report & Accurate Intraday Trading Signals - خودرو بانک
Can Spyre Therapeutics Inc. withstand a market correctionMarket Rally & Free Low Drawdown Momentum Trade Ideas - خودرو بانک
Published on: 2025-09-01 18:05:22 - خودرو بانک
Will Spyre Therapeutics Inc. bounce back from current supportWeekly Trade Review & Verified Short-Term Plans - Newser
Real time scanner hits for Spyre Therapeutics Inc. explainedMarket Movement Recap & Entry Point Confirmation Signals - Newser
Finanzdaten der Spyre Therapeutics Inc-Aktie (SYRE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Spyre Therapeutics Inc-Aktie (SYRE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Albers Jeffrey W. | Director |
Nov 06 '24 |
Sale |
36.76 |
6,700 |
246,313 |
27,360 |
| Albers Jeffrey W. | Director |
Oct 25 '24 |
Sale |
36.43 |
300 |
10,929 |
34,060 |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):